Published in AMB Express on March 14, 2017
A modified uronic acid carbazole reaction. Anal Biochem (1962) 34.83
Molecular cloning and characterization of chondroitin polymerase from Escherichia coli strain K4. J Biol Chem (2002) 1.24
Microbial production of hyaluronic acid: current state, challenges, and perspectives. Microb Cell Fact (2011) 1.09
Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow. Appl Microbiol Biotechnol (2012) 0.94
A complete hyaluronan hydrodynamic characterization using a size exclusion chromatography-triple detector array system during in vitro enzymatic degradation. Anal Biochem (2010) 0.92
Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications. Appl Microbiol Biotechnol (2009) 0.89
Quantitative analysis of intracellular sugar phosphates and sugar nucleotides in encapsulated streptococci using HPAEC-PAD. Biotechnol J (2009) 0.88
Production of chondroitin in metabolically engineered E. coli. Metab Eng (2014) 0.85
Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. Ther Adv Musculoskelet Dis (2010) 0.85
A microbiological-chemical strategy to produce chondroitin sulfate A,C. Angew Chem Int Ed Engl (2011) 0.83
Effect of a solution of hyaluronic acid-chondroitin sulfate-N-acetyl glucosamine on the repair response of cartilage to single-impact load damage. Am J Vet Res (2012) 0.83
Understanding plasmid effect on hyaluronic acid molecular weight produced by Streptococcus equi subsp. zooepidemicus. Metab Eng (2009) 0.83
Chondroitin sulphate: a focus on osteoarthritis. Glycoconj J (2016) 0.81
Isolation of an Escherichia coli K4 kfoC mutant over-producing capsular chondroitin. Microb Cell Fact (2010) 0.80
Homologous overexpression of RfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide. Microb Cell Fact (2013) 0.80
Biotechnological Chondroitin a Novel Glycosamminoglycan With Remarkable Biological Function on Human Primary Chondrocytes. J Cell Biochem (2016) 0.80
Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges. Eur J Pharm Biopharm (2015) 0.80
A multi-analytical approach to better assess the keratan sulfate contamination in animal origin chondroitin sulfate. Anal Chim Acta (2016) 0.80
Present and future medical applications of microbial exopolysaccharides. Front Microbiol (2015) 0.79
Hyaluronan: More than just a wrinkle filler. Glycobiology (2016) 0.79
Synthesis of Thermogelling Poly(N-isopropylacrylamide)-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering. J Vis Exp (2016) 0.78
Ratio of intracellular precursors concentration and their flux influences hyaluronic acid molecular weight in Streptococcus zooepidemicus and recombinant Lactococcus lactis. Bioresour Technol (2014) 0.78
Efficient biosynthesis of polysaccharides chondroitin and heparosan by metabolically engineered Bacillus subtilis. Carbohydr Polym (2015) 0.78
Short-term effect of the combination of hyaluronic acid, chondroitin sulfate, and keratin matrix on early symptomatic knee osteoarthritis. Eur J Rheumatol (2015) 0.78
A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn (2016) 0.77
Understanding the influence of phosphatidylcholine on the molecular weight of hyaluronic acid synthesized by Streptococcus zooepidemicus. Appl Biochem Biotechnol (2011) 0.77
Engineering a branch of the UDP-precursor biosynthesis pathway enhances the production of capsular polysaccharide in Escherichia coli O5:K4:H4. Biotechnol J (2015) 0.77
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence. Ther Adv Urol (2015) 0.77
Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms. Microb Cell Fact (2016) 0.77